Next Article in Journal
An Open View on SARS-CoV-2 Infection
Next Article in Special Issue
Deciphering Microbial Composition in Patients with Inflammatory Bowel Disease: Implications for Therapeutic Response to Biologic Agents
Previous Article in Journal
Rapid Visual Detection of Methicillin-Resistant Staphylococcus aureus in Human Clinical Samples via Closed LAMP Assay Targeting mecA and spa Genes
Previous Article in Special Issue
A Machine Learning-Based Diagnostic Model for Crohn’s Disease and Ulcerative Colitis Utilizing Fecal Microbiome Analysis
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Microorganisms
Volume 12
Issue 1
10.3390/microorganisms12010158
microorganisms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Correction to Microorganisms 2023, 11(11), 2616.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Mao et al. Gut Bacterial Community Determines the Therapeutic Effect of Ginsenoside on Canine Inflammatory Bowel Disease by Modulating the Colonic Mucosal Barrier. Microorganisms 2023, 11, 2616

by
Aipeng Mao
1,
Weigang Zhao
1,
Yuhang Zhu
2,
Fantao Kong
1,
Danyang Chen
1,
Huazhe Si
2,* and
Chao Xu
1,*
1
Institute of Special Animal and Plant Sciences, Chinese Academy of Agricultural Sciences, Research Center for Microbial Feed Engineering of Special Animals in Jilin Province, Innovation Center for Feeding and Utilization of Special Animals in Jilin Province, Changchun 130112, China
2
College of Animal Science and Technology, Jilin Agricultural University, Changchun 130118, China
*
Authors to whom correspondence should be addressed.
Microorganisms 2024, 12(1), 158; https://doi.org/10.3390/microorganisms12010158
Submission received: 21 December 2023 / Accepted: 4 January 2024 / Published: 12 January 2024
(This article belongs to the Special Issue The Role of Gut Microbiota in Inflammatory Bowel Disease: Mechanisms and Novel Therapeutic Approaches)
Versions Notes
The authors wish to make the following corrections to this paper [1]:
In Section 1: Introduction, paragraph 4, lines 1–2, the author mistakenly wrote: “Dogs are excellent experimental animal models in many types of biomedical research studies, and most diseases in dogs are homologous to humans [30–33]”.
The correct version should be as follows:
“Dogs are the experimental animal model used in many types of biomedical research studies [30], and some diseases in dogs are homologous to humans [31–33]. However, there is also growing evidence that the dog model is often not sufficiently justified and characterized as a relevant model for the human disease being studied [30].”
The reference order will also be updated accordingly.
The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. The original publication has also been updated.

Reference

  1. Mao, A.; Zhao, W.; Zhu, Y.; Kong, F.; Chen, D.; Si, H.; Xu, C. Gut Bacterial Community Determines the Therapeutic Effect of Ginsenoside on Canine Inflammatory Bowel Disease by Modulating the Colonic Mucosal Barrier. Microorganisms 2023, 11, 2616. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Mao, A.; Zhao, W.; Zhu, Y.; Kong, F.; Chen, D.; Si, H.; Xu, C. Correction: Mao et al. Gut Bacterial Community Determines the Therapeutic Effect of Ginsenoside on Canine Inflammatory Bowel Disease by Modulating the Colonic Mucosal Barrier. Microorganisms 2023, 11, 2616. Microorganisms 2024, 12, 158. https://doi.org/10.3390/microorganisms12010158

AMA Style

Mao A, Zhao W, Zhu Y, Kong F, Chen D, Si H, Xu C. Correction: Mao et al. Gut Bacterial Community Determines the Therapeutic Effect of Ginsenoside on Canine Inflammatory Bowel Disease by Modulating the Colonic Mucosal Barrier. Microorganisms 2023, 11, 2616. Microorganisms. 2024; 12(1):158. https://doi.org/10.3390/microorganisms12010158

Chicago/Turabian Style

Mao, Aipeng, Weigang Zhao, Yuhang Zhu, Fantao Kong, Danyang Chen, Huazhe Si, and Chao Xu. 2024. "Correction: Mao et al. Gut Bacterial Community Determines the Therapeutic Effect of Ginsenoside on Canine Inflammatory Bowel Disease by Modulating the Colonic Mucosal Barrier. Microorganisms 2023, 11, 2616" Microorganisms 12, no. 1: 158. https://doi.org/10.3390/microorganisms12010158

APA Style

Mao, A., Zhao, W., Zhu, Y., Kong, F., Chen, D., Si, H., & Xu, C. (2024). Correction: Mao et al. Gut Bacterial Community Determines the Therapeutic Effect of Ginsenoside on Canine Inflammatory Bowel Disease by Modulating the Colonic Mucosal Barrier. Microorganisms 2023, 11, 2616. Microorganisms, 12(1), 158. https://doi.org/10.3390/microorganisms12010158

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop